One scientist who has been seen to study cancer and aging is Mikhail Blagosklonny. When it comes to education Mikhail has a Ph.D. in cardiology and experimental medicine and an MD in Internal Medicine.
He was a student of the First Pavlov State Medical University located in St. Petersburg, and this is where he graduated with his honors. Apart from studying cancer and aging, he is also a professor of oncology in one of New York’s Institute, Roswell Park Cancer Institute.
Before working at Roswell Park, Mikhail Blagosklonny worked with the New York Medical College in the year 2002 as an associate professor. Later, he took a role of senior scientist at Ordway Research Institute. He continued working with Ordway for nearly seven years before joining Roswell as a professor.
Getting Strong resorted that when it comes to studying cancer, Mikhail Blagosklonny majorly focuses on cancer therapy which is seen to protect the healthy cells from being damaged.
In the role of TOR signaling, Mikhail Blagosklonny has formulated a theory of fighting cancer and slowing the aging process. According to his theory, he argues that using a drug called rapamycin helps in the dealing with the aging process. Rapamycin is a cancer drug that Mikhail has advocated passionately from his extensive research.
According to Nature.com, Mikhail Blagosklonny has a life outside his research as an editor in chief of Aging, which is a medical journal which is peer-reviewed. The medical journal majorly focuses on senescence gerontology and mechanisms of aging.
Apart from Aging, he is also an editor in chief at Cell Cycle which is a biweekly journal majorly focusing on cell biology and reviewed by peers. Mikhail is known for having authored more than two hundred articles.
He has also made tremendous contributions in his research into a variety of field such as cellular biology and molecular. With his passion, he believes he will one day have answers to all his questions including aging and cancer.